Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1972 Sep;24(3):398–404. doi: 10.1128/am.24.3.398-404.1972

Comparison of Immunization Methods for Producing Reference Adenovirus Antisera in Horses

John C Hierholzer 1, William C Gamble 1, Kenneth D Quist 1, W Adrian Chappell 1
PMCID: PMC376530  PMID: 4562476

Abstract

Horses were immunized by a variety of inoculation procedures designed to determine the most efficient method of producing antisera to adenovirus types 25 to 31. The procedures evaluated included immunization by (i) direct intravenous (iv) injection, (ii) iv infusion, (iii) intramuscular (im) injection of virus with and without Freund's incomplete adjuvant, (iv) combined iv and im injections, and (v) combined iv infusion and im injection. The im schedule (no. 3) was superior to the others in terms of immunizing antigen and time required, and hemagglutination-inhibition (HI) and serum-neutralizing (SN) antibody levels produced. HI and SN tests performed with sera before and after heating at 56 C for 30 min showed that heat-inactivation was not necessary for tests with equine antisera.

Full text

PDF
398

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altemeier W. A., 3rd, Mundon F. K., Top F. H., Jr, Russell P. K. Method for extracting viral hemagglutination-inhibiting antibodies from the nonspecific inhibitors of serum. Appl Microbiol. 1970 May;19(5):785–790. doi: 10.1128/am.19.5.785-790.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blacklow N. R., Hoggan M. D., Sereno M. S., Brandt C. D., Kim H. W., Parrott R. H., Chanock R. M. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol. 1971 Oct;94(4):359–366. doi: 10.1093/oxfordjournals.aje.a121331. [DOI] [PubMed] [Google Scholar]
  3. DeMeio J. L., DeSanctis A. N. Heat-labile factor necessary for hemagglutination-inhibition testing of horse sera. Appl Microbiol. 1971 May;21(5):860–861. doi: 10.1128/am.21.5.860-861.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dowdle W. R., Lambriex M., Hierholzer J. C. Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test. Appl Microbiol. 1971 Apr;21(4):718–722. doi: 10.1128/am.21.4.718-722.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hampil B., Melnick J. L. Method for testing virus stocks for viral contaminants. Appl Microbiol. 1969 Jan;17(1):17–20. doi: 10.1128/am.17.1.17-20.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hierholzer J. C., Dowdle W. R. Hemagglutination properties of adenovirus types 20, 25, and 28. Proc Soc Exp Biol Med. 1970 Jun;134(2):482–488. doi: 10.3181/00379727-134-34817. [DOI] [PubMed] [Google Scholar]
  7. Hierholzer J. C., Dowdle W. R. Immunological basis of the adenovirus 8-9 cross-reaction. J Virol. 1970 Dec;6(6):782–787. doi: 10.1128/jvi.6.6.782-787.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hierholzer J. C., Suggs M. T., Hall E. C. Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol. 1969 Nov;18(5):824–833. doi: 10.1128/am.18.5.824-833.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hierholzer J. C., Suggs M. T. Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions. Appl Microbiol. 1969 Nov;18(5):816–823. doi: 10.1128/am.18.5.816-823.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoggan M. D., Blacklow N. R., Rowe W. P. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A. 1966 Jun;55(6):1467–1474. doi: 10.1073/pnas.55.6.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. LUCAS J. B., JOHNSTON J. G., Jr, KAYE H. S., BUCCA M. A., ROBINSON R. Q. PRODUCTION OF ADENOVIRUS ANTISERUMS IN HORSES. Public Health Rep. 1965 Jul;80:647–652. [PMC free article] [PubMed] [Google Scholar]
  13. RAFAJKO R. R. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA. Am J Hyg. 1964 May;79:310–319. doi: 10.1093/oxfordjournals.aje.a120385. [DOI] [PubMed] [Google Scholar]
  14. ROSEN L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg. 1960 Jan;71:120–128. doi: 10.1093/oxfordjournals.aje.a120085. [DOI] [PubMed] [Google Scholar]
  15. ROSEN L., BARON S., BELL J. A. Four newly recognized adenoviruses. Proc Soc Exp Biol Med. 1961 Jun;107:434–437. doi: 10.3181/00379727-107-26648. [DOI] [PubMed] [Google Scholar]
  16. ROSEN L., HOVIS J. F., BELL J. A. Further observation on typing adenoviruses and a description of two possible additional serotypes. Proc Soc Exp Biol Med. 1962 Aug-Sep;110:710–713. doi: 10.3181/00379727-110-27626. [DOI] [PubMed] [Google Scholar]
  17. Stevens D. A., Schaeffer M., Fox J. P., Brandt C. D., Romano M. Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am J Epidemiol. 1967 Nov;86(3):617–633. doi: 10.1093/oxfordjournals.aje.a120771. [DOI] [PubMed] [Google Scholar]
  18. UCHIDA S., HOSHIKA T., YAMAMOTO H., KOIKE K., KOSEKI S., FURUNO A. Relationships between types of adenovirus indicated by heterologous neutralization. Jpn J Exp Med. 1959 Apr;29(2):121–129. [PubMed] [Google Scholar]
  19. WIGAND R., BAUER H., LANG F., ADAM W. NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS. Arch Gesamte Virusforsch. 1965;15:188–199. doi: 10.1007/BF01257730. [DOI] [PubMed] [Google Scholar]
  20. Wigand R., Fliedner D. Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses. Arch Gesamte Virusforsch. 1968;24(3):245–256. doi: 10.1007/BF01241296. [DOI] [PubMed] [Google Scholar]
  21. Wigand R. Serologische Beziehungen der Adenoviren der Gruppe II. Arch Gesamte Virusforsch. 1968;23(1):40–47. [PubMed] [Google Scholar]
  22. Zolotarskaia E. E., Dreizin R. S. Ingibitory gemaggliutinatsii adenovirusov i spontannye gamaggliutininy v syvorotkakh zhivotnykh i cheloveka. Vopr Virusol. 1968 Jan-Feb;13(1):84–88. [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES